MicroRNA-223-3p inhibits oxidized low-density lipoprotein-mediated NLRP3 inflammasome activation via directly targeting NLRP3 and FOXO3
- 7 June 2022
- journal article
- research article
- Published by IOS Press in Clinical Hemorheology and Microcirculation
- Vol. 81 (3), 241-253
- https://doi.org/10.3233/ch-211232
Abstract
BACKGROUND: MicroRNAs (miRNAs) have emerged as crucial players in the initiation and development of atherosclerosis (AS), and the low miR-223-3p level is observed in AS patients. However, the function and mechanism behind miR-223-3p in AS progressionKeywords
This publication has 47 references indexed in Scilit:
- LOX-1, OxLDL, and AtherosclerosisMediators of Inflammation, 2013
- Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic PigsPLOS ONE, 2013
- Activation and regulation of the inflammasomesNature Reviews Immunology, 2013
- NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223The Journal of Immunology, 2012
- FoxOs Integrate Pleiotropic Actions of Insulin in Vascular Endothelium to Protect Mice from AtherosclerosisCell Metabolism, 2012
- Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cellsAtherosclerosis, 2010
- Inflammasomes: too big to missJCI Insight, 2009
- Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophagesCellular Microbiology, 2006
- Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69Phytomedicine, 2001
- A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblastsNature, 1977